Quick Shot Corporation – Trademark Portfolio
Entity Type: 03
Quick Shot Corporation holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include QS, TOPSHOT, and QS QUICK SHOT CORPORATION ANIMAL FLUID INJECTION SYSTEMS. The owner is based in Dallas, TX.
17818 Davenport Rd., Suite 119
Dallas, TX 75252
Showing of trademarks Trademarks
Trademark Classifications
Quick Shot Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Quick Shot Corporation have?
Quick Shot Corporation has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 7 abandoned.
What trademark classes does Quick Shot Corporation file in?
Quick Shot Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Quick Shot Corporation's most well-known trademarks?
Quick Shot Corporation's registered trademark portfolio includes well-known marks such as QS, TOPSHOT, and QS QUICK SHOT CORPORATION ANIMAL FLUID INJECTION SYSTEMS. These are among 4 currently registered trademarks in the portfolio.
What is Quick Shot Corporation's trademark registration success rate?
Quick Shot Corporation has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.